Free Trial

Bill Sutherland Analyst Performance

Director of Research at Benchmark

Bill Sutherland is a stock analyst at Benchmark focused in the medical sector, covering 16 publicly traded companies. Over the past year, Bill Sutherland has issued 22 stock ratings, including buy and hold recommendations. While full access to Bill Sutherland's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Bill Sutherland's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
51 Last 8 Years
Buy Recommendations
94.00% 47 Buy Ratings
Companies Covered
16 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy94.0%47 ratings
Hold6.0%3 ratings
Sell0.0%0 ratings

Out of 50 total stock ratings issued by Bill Sutherland at Benchmark, the majority (94.0%) have been Buy recommendations, followed by 6.0% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
62.5% of companies on NASDAQ
10 companies
NYSE
31.3% of companies on NYSE
5 companies
NYSEAMERICAN
6.3% of companies on NYSEAMERICAN
1 company

Bill Sutherland, an analyst at Benchmark, currently covers 16 companies listed on NASDAQ, NYSE and NYSEAMERICAN, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
10 companies
62.5%
Business Services
5 companies
31.3%
Finance
1 company
6.3%

Bill Sutherland of Benchmark specializes in stock coverage within the Medical sector, with additional focus on Business Services and Finance companies.

Coverage Industries

IndustryPercentage
MEDICAL SERVICES
4 companies
25.0%
MEDICAL INFO SYS
2 companies
12.5%
STAFFING
2 companies
12.5%
BUSINESS SVCS
1 company
6.3%
REIT - EQTY TRUST - OTHER
1 company
6.3%
MED - HMO
1 company
6.3%
CONSULTING
1 company
6.3%
MED PRODUCTS
1 company
6.3%
NURSING & PERSONAL CARE FACILITIES
1 company
6.3%
MED - OUTP/HM CRE
1 company
6.3%
ADVERTISING/MKTG SVCS
1 company
6.3%

About Bill Sutherland

Bill Sutherland is an Equity Research Analyst focused on Healthcare Services and Digital Health. His coverage focus includes companies providing virtual care and remote patient monitoring, value-based care, and post-acute and alternate site healthcare services. He was previously a senior research analyst with Northland Securities, Director of Research with Boenning & Scattergood, and a senior research analyst with Janney Montgomery Scott and Wheat First Butcher & Singer (Wells Fargo). Bill holds a BA from the University of North Carolina at Chapel Hill and an MBA from Columbia University.
Follow on LinkedIn

Bill Sutherland's Ratings History at Benchmark

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
HeartBeam, Inc. stock logo
BEAT
HeartBeam
5/15/2026Lower Price Target$1.04$5.00Speculative Buy
Cross Country Healthcare, Inc. stock logo
CCRN
Cross Country Healthcare
5/8/2026Downgrade$13.17Hold
Healthcare Services Group, Inc. stock logo
HCSG
Healthcare Services Group
4/23/2026Boost Price Target$22.89$30.00Buy
RCM Technologies, Inc. stock logo
RCMT
RCM Technologies
4/8/2026Boost Price Target$27.20$36.00Buy
Agilon Health, Inc. stock logo
AGL
Agilon Health
4/2/2026Boost Price Target$10.27$13.00Buy
CoreCivic, Inc. stock logo
CXW
CoreCivic
3/24/2026Initiated Coverage$20.24$28.00Buy
Omnicell, Inc. stock logo
OMCL
Omnicell
3/13/2026Reiterated Rating$35.05Buy
Cross Country Healthcare, Inc. stock logo
CCRN
Cross Country Healthcare
3/5/2026Set Price Target$9.70$14.00
Cross Country Healthcare, Inc. stock logo
CCRN
Cross Country Healthcare
3/5/2026Upgrade$9.13$14.00Buy
Select Medical Holdings Corporation stock logo
SEM
Select Medical
3/4/2026Downgrade$16.25Hold
Surgery Partners, Inc. stock logo
SGRY
Surgery Partners
3/3/2026Reiterated Rating$13.16Buy
Healthcare Services Group, Inc. stock logo
HCSG
Healthcare Services Group
2/12/2026Reiterated Rating$21.59Buy
Omnicell, Inc. stock logo
OMCL
Omnicell
2/2/2026Boost Price Target$48.50$60.00Buy
Huron Consulting Group Inc. stock logo
HURN
Huron Consulting Group
12/24/2025Boost Price Target$179.96$215.00Buy
HeartBeam, Inc. stock logo
BEAT
HeartBeam
12/11/2025Reiterated Rating$1.54Speculative Buy
Omnicell, Inc. stock logo
OMCL
Omnicell
12/9/2025Boost Price Target$43.55$50.00Buy
Surgery Partners, Inc. stock logo
SGRY
Surgery Partners
11/11/2025Lower Price Target$16.03$30.00Buy
Omnicell, Inc. stock logo
OMCL
Omnicell
10/31/2025Boost Price Target$33.52$45.00Buy
Huron Consulting Group Inc. stock logo
HURN
Huron Consulting Group
10/27/2025Boost Price Target$154.17$180.00Buy
Healthcare Services Group, Inc. stock logo
HCSG
Healthcare Services Group
10/23/2025Boost Price Target$18.85$24.00Buy
Agilon Health, Inc. stock logo
AGL
Agilon Health
8/6/2025Lower Price Target$23.30$37.50Buy
Healthcare Services Group, Inc. stock logo
HCSG
Healthcare Services Group
7/24/2025Boost Price Target$14.05$19.00Buy
Nutex Health Inc. stock logo
NUTX
Nutex Health
5/15/2025Boost Price Target$171.57$300.00Buy
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
5/14/2025Reiterated Rating$1.64$4.00Buy
Omnicell, Inc. stock logo
OMCL
Omnicell
5/7/2025Lower Price Target$24.75$40.00Buy
Surgery Partners, Inc. stock logo
SGRY
Surgery Partners
4/21/2025Reiterated Rating$20.31$35.00Buy
Huron Consulting Group Inc. stock logo
HURN
Huron Consulting Group
3/26/2025Reiterated Rating$144.12$165.00Buy
RCM Technologies, Inc. stock logo
RCMT
RCM Technologies
3/21/2025Lower Price Target$15.67$30.00Buy
Huron Consulting Group Inc. stock logo
HURN
Huron Consulting Group
2/26/2025Boost Price Target$152.53$165.00Buy
Omnicell, Inc. stock logo
OMCL
Omnicell
2/4/2025Reiterated Rating$43.60$62.00Buy